Ask a Black Doctor: Navigating Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML), a slow-growing blood cancer, affects people of all backgrounds, but understanding its nuances within the Black community is crucial. While less common than some other cancers, CML presents unique challenges for Black patients, including potential disparities in diagnosis, treatment access, and outcomes. This article aims to shed light on CML, addressing its symptoms, diagnosis, treatment options, and importantly, the specific considerations for Black individuals. In this Q&A, Black doctor Dr. Ruemu Birhiray, a hematologist/oncologist and clinical investigator at Hematology Oncology of Indiana in Indianapolis, explains chronic myeloid leukemia (CML), its treatment options, and what patients should know about this blood cancer. BDO: What exactly is chronic myeloid leukemia? Dr. Reumu Birhiray: Chronic myeloid leukemia (CML) is a type of blood cancer that belongs to the group of myeloid disorders. It affects the bone marrow, specifically the myeloid cells, which are responsible for fighting infections. CML is characterized by the presence of a unique gene mutation called the Philadelphia chromosome. Unlike acute myeloid leukemia, CML involves more mature cells of myeloid origin. If left untreated, most people would die from CML within 3 years of diagnosis. Q: Are there any known causes or risk factors for CML?...